MedPath

Nimedine

Brand Name: Nimedine

Generic Name: Imipenem (as monohydrate) + Cilastatin (as sodium)

Active
Registration Number

DRP-16072

Dosage Form

Powder for Injection (IV)

Issuance Date

November 1, 2024

Expiry Date

August 15, 2026

Product Information

Philippine FDA product specifications and classification details

Product Specifications

Dosage Strength500 mg/500 mg
Packaging20 mL-capacity type III glass vial with bromobutyl rubber Iglass vial with bromobutyl rubber stopper and aluminum cap with plastic flip-off seal (Box aluminum of 1's)

Classification

C
Classification
Prescription (Rx) Drug
P
Pharmacologic
Antibacterial (Carbapenem)
A
Application
Initial
Philippine FDA Classification

Active Ingredients (2)

Complete list of active ingredients in this pharmaceutical product.

Imipenem (as monohydrate)Active
Monograph: imipenem (as monohydrate)
Cilastatin (as sodium)Active
Monograph: cilastatin (as sodium)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

Product

Company

Legal

© 2025 MedPath, Inc. All rights reserved.

MedPath - Medical Intelligence Platform